Abstract: Disclosed are methods of reducing or inhibiting the motility and/or proliferative abilities of a neural tumor cell, or of enhancing apoptosis or differentiation of the tumor cell, in which a vector comprising a nucleic acid encoding a cytoplasmic domain of a neurotrophin receptor tyrosine kinase, is transferred to the tumor cell such that the nucleic acid is expressed. The methods of the invention result in reduced tumorigenicity of neural tumors.
Type:
Grant
Filed:
March 12, 1997
Date of Patent:
August 7, 2001
Assignees:
University of Massachusetts Medical Center, Worcester Foundation for Biomedical Research
Inventors:
Alonzo H. Ross, Lawrence D. Recht, Mahesh B. Lachyankar
Abstract: Compositions of antisense oligonucleotides conjugated to peptides of a plurality of N-methylpyrrolecarboxamides linked by peptide bonds is provided. The compositions form stable hybridization complexes with DNA and can be used for any purpose which involves hybridizing an oligonucleotide to a DNA molecule, such as in antisense procedures. A method for enhancing oligonucleotide binding to a target is also provided. The method involves the step of hybridizing the target DNA with an oligonucleotide-peptide composition.
Type:
Grant
Filed:
July 15, 1996
Date of Patent:
September 21, 1999
Assignee:
Worcester Foundation for Biomedical Research
Abstract: Disclosed is a method of selecting for a compound which modulates the behavior of an insect. In this method, electrical characteristics of an insect chemoreceptor neuron in the presence of control stimulation, then a known chemical modulator of insect activity, and then a test compound are measured after the neuron is contacted therewith. These measurements are compared and the test compound classified based on this comparison.
Type:
Grant
Filed:
October 16, 1995
Date of Patent:
June 30, 1998
Assignee:
Worcester Foundation For Biomedical Research
Abstract: The invention provides methods and materials for antisense oligonucleotide therapy against active pathogenic infection by drug resistant or drug sensitive pathogens, including Plasmodium falciparum.
Type:
Grant
Filed:
January 7, 1994
Date of Patent:
April 1, 1997
Assignee:
Worcester Foundation for Biomedical Research, Inc.
Abstract: Disclosed are methods of producing a synthetic oligonucleotide of selected nucleotide sequence which is internally functionalized at at least one selected location with an aminoalkyl-phosphoramidate and labelled with a nonradioactive material. Also disclosed are oligonucleotides produced by this method.
Type:
Grant
Filed:
March 3, 1994
Date of Patent:
October 8, 1996
Assignee:
Worcester Foundation for Biomedical Research
Abstract: Disclosed are methods of producing a synthetic oligonucleotide of selected nucleotide sequence which is internally functionalized at least one selected location with an aminoalkylphosphotriester, and labelled with a nonradioactive material. Also disclosed are oligonucleotides produced by this method.
Type:
Grant
Filed:
December 16, 1994
Date of Patent:
July 30, 1996
Assignee:
Worcester Foundation for Biomedical Research
Abstract: Disclosed are methods of producing a synthetic oligonucleotide of selected nucleotide sequence which is internally functionalized at at least one selected location with an aminoalkylphosphorothioamidate and labelled with a nonradioactive material. Also disclosed are oligonucleotides produced by this method.
Type:
Grant
Filed:
December 16, 1994
Date of Patent:
July 16, 1996
Assignee:
Worcester Foundation for Biomedical Research